Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)
CNY 6.27
(0.48%)
CNY 6.27
(0.48%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 109.44 Million CNY | -8.91% |
| 2022 | 120.15 Million CNY | -8.83% |
| 2021 | 131.79 Million CNY | -25.96% |
| 2020 | 178 Million CNY | -6.71% |
| 2019 | 190.8 Million CNY | -26.62% |
| 2018 | 260 Million CNY | -24.63% |
| 2017 | 344.96 Million CNY | 20.34% |
| 2016 | 286.66 Million CNY | 3328.03% |
| 2015 | 8.36 Million CNY | -79.09% |
| 2014 | 40 Million CNY | 0.0% |
| 2013 | 40 Million CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 40 Million CNY | -24.1% |
| 2008 | 52.7 Million CNY | 24.0% |
| 2007 | 42.5 Million CNY | -51.43% |
| 2006 | 87.5 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 95.12 Million CNY | -13.09% |
| 2024 Q2 | 99.28 Million CNY | 4.38% |
| 2024 Q3 | 79.79 Million CNY | -19.63% |
| 2023 Q4 | 109.44 Million CNY | 21.47% |
| 2023 Q2 | 130.13 Million CNY | 8.31% |
| 2023 Q1 | 120.15 Million CNY | 0.0% |
| 2023 Q3 | 90.1 Million CNY | -30.76% |
| 2023 FY | 109.44 Million CNY | -8.91% |
| 2022 Q2 | 103.47 Million CNY | 0.56% |
| 2022 Q1 | 102.9 Million CNY | -21.92% |
| 2022 FY | 120.15 Million CNY | -8.83% |
| 2022 Q4 | 120.15 Million CNY | -19.98% |
| 2022 Q3 | 150.15 Million CNY | 45.12% |
| 2021 FY | 131.79 Million CNY | -25.96% |
| 2021 Q2 | 218 Million CNY | 47.3% |
| 2021 Q4 | 131.79 Million CNY | -25.96% |
| 2021 Q1 | 148 Million CNY | -16.85% |
| 2021 Q3 | 178 Million CNY | -18.35% |
| 2020 Q2 | 170.8 Million CNY | -22.64% |
| 2020 FY | 178 Million CNY | -6.71% |
| 2020 Q3 | 140 Million CNY | -18.03% |
| 2020 Q1 | 220.8 Million CNY | 15.72% |
| 2020 Q4 | 178 Million CNY | 27.14% |
| 2019 Q2 | 220 Million CNY | -15.38% |
| 2019 Q3 | 220.8 Million CNY | 0.36% |
| 2019 FY | 190.8 Million CNY | -26.62% |
| 2019 Q1 | 260 Million CNY | 0.0% |
| 2019 Q4 | 190.8 Million CNY | -13.59% |
| 2018 Q4 | 260 Million CNY | -18.75% |
| 2018 Q1 | 344.96 Million CNY | 0.0% |
| 2018 Q3 | 320 Million CNY | 6.67% |
| 2018 Q2 | 300 Million CNY | -13.03% |
| 2018 FY | 260 Million CNY | -24.63% |
| 2017 Q2 | 389.14 Million CNY | 34.76% |
| 2017 Q4 | 344.96 Million CNY | -9.85% |
| 2017 FY | 344.96 Million CNY | 20.34% |
| 2017 Q3 | 382.65 Million CNY | -1.67% |
| 2017 Q1 | 288.77 Million CNY | 0.74% |
| 2016 FY | 286.66 Million CNY | 3328.03% |
| 2016 Q4 | 286.66 Million CNY | 1107.89% |
| 2016 Q3 | 23.73 Million CNY | 37.64% |
| 2016 Q1 | 12.65 Million CNY | 51.3% |
| 2016 Q2 | 17.24 Million CNY | 36.28% |
| 2015 Q1 | 40 Million CNY | 0.0% |
| 2015 FY | 8.36 Million CNY | -79.09% |
| 2015 Q4 | 8.36 Million CNY | 0.0% |
| 2015 Q3 | - CNY | -100.0% |
| 2015 Q2 | 40 Million CNY | 0.0% |
| 2014 Q4 | 40 Million CNY | 0.0% |
| 2014 Q3 | 40 Million CNY | 0.0% |
| 2014 Q2 | 40 Million CNY | 0.0% |
| 2014 Q1 | 40 Million CNY | 0.0% |
| 2014 FY | 40 Million CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 FY | 40 Million CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q4 | 40 Million CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2010 Q2 | 23.5 Million CNY | -41.25% |
| 2010 Q4 | - CNY | -100.0% |
| 2010 Q3 | 13.5 Million CNY | -42.55% |
| 2010 Q1 | 40 Million CNY | 0.0% |
| 2010 FY | - CNY | -100.0% |
| 2009 Q2 | 38.5 Million CNY | 0.0% |
| 2009 Q4 | 40 Million CNY | 0.0% |
| 2009 FY | 40 Million CNY | -24.1% |
| 2008 FY | 52.7 Million CNY | 24.0% |
| 2007 FY | 42.5 Million CNY | -51.43% |
| 2006 FY | 87.5 Million CNY | 0.0% |